Daenen S - Search Results

1

Cost effectiveness of itraconazole in the prophylaxis of invasive fungal infections.

de Vries R, Daenen S, Tolley K, Glasmacher A, Prentice A, Howells S, Christopherson H, de Jong-van den Berg LT, Postma MJ. de Vries R, et al. Among authors: daenen s. Pharmacoeconomics. 2008;26(1):75-90. doi: 10.2165/00019053-200826010-00007. Pharmacoeconomics. 2008. PMID: 18088160 Free article.

2

Cost benefit and cost effectiveness of antifungal prophylaxis in immunocompromised patients treated for haematological malignancies: reviewing the available evidence.

Pechlivanoglou P, De Vries R, Daenen SM, Postma MJ. Pechlivanoglou P, et al. Pharmacoeconomics. 2011 Sep;29(9):737-51. doi: 10.2165/11588370-000000000-00000. Pharmacoeconomics. 2011. PMID: 21657801 Review.

3

Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review.

Pechlivanoglou P, Le HH, Daenen S, Snowden JA, Postma MJ. Pechlivanoglou P, et al. Among authors: daenen s. J Antimicrob Chemother. 2014 Jan;69(1):1-11. doi: 10.1093/jac/dkt329. Epub 2013 Aug 23. J Antimicrob Chemother. 2014. PMID: 23975736 Review.

4

Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study.

Löwenberg B, Beck J, Graux C, van Putten W, Schouten HC, Verdonck LF, Ferrant A, Sonneveld P, Jongen-Lavrencic M, von Lilienfeld-Toal M, Biemond BJ, Vellenga E, Breems D, de Muijnck H, Schaafsma R, Verhoef G, Döhner H, Gratwohl A, Pabst T, Ossenkoppele GJ, Maertens J; Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON); German Austrian AML Study Group (AMLSG); Swiss Group for Clinical Cancer Research Collaborative Group (SAKK). Löwenberg B, et al. Blood. 2010 Apr 1;115(13):2586-91. doi: 10.1182/blood-2009-10-246470. Epub 2010 Jan 26. Blood. 2010. PMID: 20103782 Free article. Clinical Trial.

5

Routine radiography does not have a role in the diagnostic evaluation of ambulatory adult febrile neutropenic cancer patients.

Oude Nijhuis CS, Gietema JA, Vellenga E, Daenen SM, De Bont ES, Kamps WA, Groen HJ, van der Jagt EJ, van der Graaf WT. Oude Nijhuis CS, et al. Among authors: daenen sm. Eur J Cancer. 2003 Nov;39(17):2495-8. doi: 10.1016/j.ejca.2003.06.002. Eur J Cancer. 2003. PMID: 14602135

6

Real-world costs of chronic lymphocytic leukaemia in the Netherlands.

Holtzer-Goor KM, Bouwmans-Frijters CA, Schaafsma MR, de Weerdt O, Joosten P, Posthuma EF, Wittebol S, Huijgens PC, Mattijssen EJ, Vreugdenhil G, Visser H, Peters WG, Erjavec Z, Wijermans PW, Daenen SM, van der Hem KG, van Oers MH, Groot CA. Holtzer-Goor KM, et al. Among authors: daenen sm. Leuk Res. 2014 Jan;38(1):84-90. doi: 10.1016/j.leukres.2013.10.029. Epub 2013 Nov 8. Leuk Res. 2014. PMID: 24268350

7

Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients.

Oude Nijhuis CSM, Vellenga E, Daenen SMGJ, van der Graaf WTA, Gietema JA, Groen HJM, Kamps WA, de Bont ESJM. Oude Nijhuis CSM, et al. Among authors: daenen smgj. Intensive Care Med. 2003 Dec;29(12):2157-2161. doi: 10.1007/s00134-003-2026-2. Epub 2003 Oct 16. Intensive Care Med. 2003. PMID: 14569424 Clinical Trial.

8

Fever and neutropenia in cancer patients: the diagnostic role of cytokines in risk assessment strategies.

Oude Nijhuis CS, Daenen SM, Vellenga E, van der Graaf WT, Gietema JA, Groen HJ, Kamps WA, de Bont ES. Oude Nijhuis CS, et al. Among authors: daenen sm. Crit Rev Oncol Hematol. 2002 Nov;44(2):163-74. doi: 10.1016/s1040-8428(01)00220-7. Crit Rev Oncol Hematol. 2002. PMID: 12413633 Review.

9

The role of oral mucositis on the systemic inflammation parameter IL-8 in febrile neutropenic cancer patients.

Stokman MA, Oude Nijhuis CS, Spijkervet FK, de Bont ES, Dijkstra PU, Daenen SM, Gietema JA, van der Graaf WT, Groen HJ, Vellenga E, Kamps WA. Stokman MA, et al. Among authors: daenen sm. Cancer Invest. 2006 Aug-Sep;24(5):479-83. doi: 10.1080/07357900600814698. Cancer Invest. 2006. PMID: 16939955

10

The predictive value of interleukin-8 (IL-8) in hospitalised patients with fever and chemotherapy-induced neutropenia.

Tromp YH, Daenen SM, Sluiter WJ, Vellenga E. Tromp YH, et al. Eur J Cancer. 2009 Mar;45(4):596-600. doi: 10.1016/j.ejca.2008.10.041. Epub 2008 Dec 16. Eur J Cancer. 2009. PMID: 19095436

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters